InsidersTradesSigma
Discover the detailed record of transactions filed by venBio Global Strategic Fund III, L.P.. Officer active across 2 companies, notably Elevation Oncology, Inc.. In total, 5 filings have been logged. Total volume traded: €2.7m. The latest transaction was disclosed on 25 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
venBio Global Strategic Fund III, L.P. is a director and insider at Elevation Oncology, Inc. and Ventyx Biosciences, Inc.